Glimesaph-T3 (Glimepiride 3mg) is a prescription oral hypoglycemic medication belonging to the second-generation sulfonylurea class. It is specifically indicated for the management of Type 2 Diabetes Mellitus in adults when lifestyle changes—such as diet, exercise, and weight loss—are no longer sufficient to maintain healthy blood glucose levels.
Glimepiride works by stimulating the pancreas to release more insulin and by helping the body use its natural insulin more efficiently. The 3mg strength provides a versatile dosing option for patients who require more than the starting dose but may not yet need the maximum strength, allowing for highly personalized glycemic control.
Key Indications:
-
Type 2 Diabetes Control: Lowers high blood sugar in patients with non-insulin-dependent diabetes.
-
HbA1c Management: Helps achieve and maintain long-term blood sugar targets to prevent complications like kidney damage, vision loss, and nerve issues.
-
Combination Therapy: Can be used as a standalone treatment or alongside other antidiabetic medications (e.g., Metformin) for enhanced results.
Why Choose Glimesaph-T3?
-
Optimized 3mg Strength: Ideal for patients undergoing dose titration to find their perfect therapeutic balance.
-
Convenient Once-Daily Dosing: Typically taken once a day with breakfast for 24-hour glucose regulation.
-
Bulk Supply: The 100-tablet box is perfect for chronic management, ensuring you have your essential medication on hand.
Important Safety Information:
-
Take with Food: Always take Glimesaph-T3 with your first main meal of the day to prevent hypoglycemia (low blood sugar).
-
Consistent Meals: Do not skip meals while taking this medication. A consistent carbohydrate intake is necessary to balance the insulin-stimulating effect.
-
Hypoglycemia Signs: Be alert for dizziness, sweating, trembling, and blurred vision. Always keep a fast-acting sugar source (like candy or juice) nearby.
-
Medical Supervision: Use only under the direction of a healthcare provider. Regular blood sugar monitoring is essential.





